FDA NDC Directory · JSON-LD · Markdown

ICATIBANT

NDC 69097-664 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerCipla USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA212446
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsICATIBANT ACETATE (30 mg/3mL)
Marketing started20200713
Package count2

External sources

Source: openFDA. Public-domain (CC0).